Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update).
Simple Summary: HER2-positive (HER2+) breast cancer is a fast-growing type of breast cancer that can have poor outcomes if not treated effectively. Over the past year, results from many important clinical trials were released, leading to improvements in how this cancer is treated. Newer treatments,...
| Publicado en: | Current Oncology Vol. 33; no. 4; pp. 200 - 225 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Apr2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |